12
Participants
Start Date
August 25, 2016
Primary Completion Date
August 6, 2017
Study Completion Date
August 31, 2017
Coagulation Factor VIIa (Recombinant)
LR769
Charlotte Maxeke Johannesburg Academic Hospital, Hemophilia Comprehensive Care, Parktown
University and Polytechnic Hospital La Fe, Hemostasis and Thrombosis Unit, Valencia
Dr. Jose Eleuterio Gonzalez Monterrey University Hospital, Monterrey
UT Southwestern Medical Center, Dallas
Hematology Research Center of the Russian Academy of Medical Sciences, Moscow
Worthwhile Clinical Trials, Lakeview Hospital, Benoni
City Scientific-Practical center for diagnosics, Kiev
National Specialized Children's Hospital OKHMATDYT, Centre for Hemostatic Pathology, Kyiv
Institute of Blood Pathology and Transfusion Medicine, Lviv
LFB USA, Inc.
INDUSTRY
Laboratoire français de Fractionnement et de Biotechnologies
INDUSTRY